Read the #GUTOnline paper by Makino et al on "Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas" via https://t.co/jrigqFiIHD @FredrikThege @Aiims1742 @MDAndersonNews #IPMN

New study in @NatureMedicine from @skopetz @MDAndersonNews and colleagues Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial https://t.co/jTY768TaFt The putative genomic mechanisms of resistance (on ctDNA) illustrated below

🚨 We are hiring! Gd 7 PDRA position to support research on new AI-based classifiers of RT response in #rectalcancer👇 https://t.co/aVTgH7gTro Funded by Stand Up to Cancer campaign for CRUK - please get in touch!

Spot our Clinical Lead @McsorleyStephen and Clinical Research Fellow @mark_j89 among the participants! 👀

An outstanding visit to @grisurgery from @MDAndersonNews #surgicalonc @MikeWhiteMD and Neal Bhutani providing insight into advanced #colorectalcancer Mx Congratulations to our research fellows/ surgical trainees for great presentations @UofGlasgow @UofGMVLS @LabSpatialNBJ

🚨 #PRODIGE44 - preop radiation for LA-BR-PDAC Phase 2 of👥110 pts Preop mFOLFIRINOX + rads🆚no rads ❌No difference R0 ❌No difference OS or PFS #ESMO24 really hitting nail in⚰️of neoadj rads in GI cancers 🎉Great news: close 50 months median OS with resection after NAT!

🚨🚨Hot off the press @NEJM In a randomized Ph II Ponsegromab, an anti-GDF15 mAB, increased weight gain, overall physical activity and reduced cachexia symptoms in patients with #cachexia and ⬆️ GDF-15 https://t.co/1oYe8OWT2O

@JenniferOgilvi @nigeljamieson @C_Roxburgh @rho37231 @drmramkent @grisurgery @GlasspoolRos @Beatson_Charity We need our teams to get us through the physical and mental challenges of cancer treatment, 👏

Enticing results reported in the TORCH study at #ASCO24 and just published in @JCO_ASCO 📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B Full paper 🔗: https://t.co/D0fUiz9wsN

Representing @grisurgery at @ACPGBI annual meeting in #Newport With Mr Stevens... Mentor, supervisor and top boss

PhD opportunity🚨: come join our team ⁦@UofGCancerSci⁩ ⁦@RadNetCRUKGla⁩ working on research developing novel AI-based classifiers of RT response in #rectalcancer. Funded by ⁦@CRUKresearch⁩. Please get in touch!👇 ⁦@LabEdwards⁩

@grisurgery Fellows leaving dinner

Those who saw the BBC article about our paper will have seen Lauren Golightly explain what life with Crohn's is like for her. Lauren is not just an great advocate but also a trainee psychologist - if you have IBD please spare 5min to fill in her survey about mental health in IBD:

Technicians are the backbone of innovation, turning ideas into reality, one experiment at a time. Keep pushing boundaries and inspiring change. Our Technicians had great time attending the @UofGTechnicians @TechsCommit Conference @UofGlasgow ! 🌟 #Networking #CPD #Technician🔬🧪

Not just IBD though - similar changes were found in #PSC (a liver disease) for which there are no treatments currently. Kudos to the amazing teams @nanostringtech and @nigeljamieson lab in Glasgow for help with this

Ecstatic and proud to share the NICHE-2 results, now published in @NEJM. Out of 111 pts, 95% had an MPR , and 68% a pCR after only 4 weeks of #neoadjuvant #immunotherapy. Grateful to the pts and colleagues who made this possible. @HaanenJohn https://t.co/h7xgmjOfjz

Delighted to see the success of our research fellows with Ross McMahon taking to the podium twice during #ASCRS24 ⁦@C_Roxburgh⁩ ⁦

Major cause of inflammatory bowel disease found Thrilled to have contributed to this important study by James Lee and team ⁦@TheCrick⁩ ⁦@UofGlasgow⁩ ⁦@UofGMVLS⁩ ⁦@LabSpatialNBJ⁩ ⁦@Nature @bbc ⁦@bbchealth⁩ #ibd

Well done @RK_McMahon presenting your research on neoadjuvant RT response in #rectalcancer at #ASCRS2024 - 2 oral presentations is a great effort @RadNetCRUKGla @grisurgery @UofGCancerSci

🆕 Receiving an epidural during labour is associated with a significant reduction in severe maternal morbidity (serious health problems during childbirth or the six weeks following birth), according to new UofG research. More ➡️ https://t.co/LxrOP7tISE